Cargando…

CD44/HA signaling mediates acquired resistance to a PI3Kα inhibitor

Most luminal breast carcinomas (BrCas) bearing PIK3CA mutations initially respond to phosphoinositide-3-kinase (PI3K)-α inhibitors, but many eventually become resistant. The underlying mechanisms of this resistance remain obscure. In this work, we showed that a CD44(high) state due to aberrant isofo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Cuixia, Sheng, Yumeng, Shi, Xiaoxing, Liu, Yiwen, He, Yiqing, Du, Yan, Zhang, Guoliang, Gao, Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538592/ https://www.ncbi.nlm.nih.gov/pubmed/33024087 http://dx.doi.org/10.1038/s41419-020-03037-0

Ejemplares similares

CD44 cross-linking increases malignancy of breast cancer via upregulation of p-Moesin
por: Hu, Song, et al.
Publicado: (2020)

CD44 activation state regulated by the CD44v10 isoform determines breast cancer proliferation
por: Guo, Qian, et al.
Publicado: (2021)

Activation of CD44 signaling in leader cells induced by tumor-associated macrophages drives collective detachment in luminal breast carcinomas
por: Gao, Feng, et al.
Publicado: (2022)

Selective killing of breast cancer cells expressing activated CD44 using CD44 ligand-coated nanoparticles in vitro and in vivo
por: Yang, Cuixia, et al.
Publicado: (2015)

CD44v6 Targeted by miR-193b-5p in the Coding Region Modulates the Migration and Invasion of Breast Cancer Cells
por: Hu, Song, et al.
Publicado: (2020)

CD44s-activated tPA/LRP1-NFκB pathway drives lamellipodia outgrowth in luminal-type breast cancer cells
por: Qiu, Yaqi, et al.
Publicado: (2023)

Cell adhesion molecule CD44v10 promotes stem-like properties in triple-negative breast cancer cells via glucose transporter GLUT1-mediated glycolysis
por: Guo, Qian, et al.
Publicado: (2022)

Combination of plasma HA and circulating M2-like monocytes may serve as a diagnostic marker for breast cancer
por: Zhang, Boke, et al.
Publicado: (2017)

Remodelling of the bone marrow microenvironment by stromal hyaluronan modulates the malignancy of breast cancer cells
por: Chen, Xiaoyan, et al.
Publicado: (2020)

The High and Low Molecular Weight Forms of Hyaluronan Have Distinct Effects on CD44 Clustering
por: Yang, Cuixia, et al.
Publicado: (2012)

HAS2-Ezrin-ER axis plays a role in acquired antiestrogen resistance of ER-positive breast cancer
por: Sun, Xiaodan, et al.
Publicado: (2022)

Understanding Hyaluronan Receptor (CD44) Interaction, HA-CD44 Activated Potential Targets in Cancer Therapeutics
por: Chaudhry, Gul-e-Saba, et al.
Publicado: (2021)

Selective Anticancer Therapy Based on a HA-CD44 Interaction Inhibitor Loaded on Polymeric Nanoparticles
por: Espejo-Román, José M., et al.
Publicado: (2022)

Reduced hyaluronan cross-linking induces breast cancer malignancy in a CAF-dependent manner
por: Zhang, Guoliang, et al.
Publicado: (2021)

Moderate Constraint Facilitates Association and Force-Dependent Dissociation of HA-CD44 Complex
por: Yao, Ziyang, et al.
Publicado: (2023)

NOD1 deficiency impairs CD44a/Lck as well as PI3K/Akt pathway
por: Hu, Yi Wei, et al.
Publicado: (2017)

Hyaluronic Acid (Ha) Binding to Cd44 Activates Rac1 and Induces Lamellipodia Outgrowth
por: Oliferenko, Snezhana, et al.
Publicado: (2000)

A correlation study of the expression of HA-CD44st and HER-2 in breast cancer
por: Ying Zhi, Lu, et al.
Publicado: (2018)

HA-Coated PLGA Nanoparticles Loaded with Apigenin for Colon Cancer with High Expression of CD44
por: Yang, Bo, et al.
Publicado: (2023)

PI3Kα Inhibitors That Inhibit Metastasis
por: Schmidt-Kittler, Oleg, et al.
Publicado: (2010)

Osteopontin inhibits osteoarthritis progression via the OPN/CD44/PI3K signal axis
por: Liu, Qing, et al.
Publicado: (2020)

Management of toxicity to isoform α-specific PI3K inhibitors
por: Nunnery, S E, et al.
Publicado: (2019)

Overexpression of PI3K p110α contributes to acquired resistance to MET inhibitor, in MET-amplified SNU-5 gastric xenografts
por: Ji, Fujian, et al.
Publicado: (2015)

Biological characterization of SN32976, a selective inhibitor of PI3K and mTOR with preferential activity to PI3Kα, in comparison to established pan PI3K inhibitors
por: Rewcastle, Gordon W, et al.
Publicado: (2017)

PI3Kδ inhibitor idelalisib in combination with BTK inhibitor ONO/GS-4059 in diffuse large B cell lymphoma with acquired resistance to PI3Kδ and BTK inhibitors
por: Yahiaoui, Anella, et al.
Publicado: (2017)

Uncovering the dual role of RHAMM as an HA receptor and a regulator of CD44 expression in RHAMM-expressing mesenchymal progenitor cells
por: Veiseh, Mandana, et al.
Publicado: (2015)

First-in-human phase Ia study of the PI3Kα inhibitor CYH33 in patients with solid tumors
por: Wei, Xiao-Li, et al.
Publicado: (2022)

Involvement of PI3K/AKT and MAPK Pathways for TNF-α Production in SiHa Cervical Mucosal Epithelial Cells Infected with Trichomonas vaginalis
por: Yang, Jung-Bo, et al.
Publicado: (2015)

Self-assembling HA/PEI/dsRNA-p21 ternary complexes for CD44 mediated small active RNA delivery to colorectal cancer
por: Feng, Chen-Lin, et al.
Publicado: (2017)

ΔNp63 drives metastasis in breast cancer cells via PI3K/CD44v6 axis
por: Di Franco, Simone, et al.
Publicado: (2016)

Anti-Inflammatory Effects of the 35kDa Hyaluronic Acid Fragment (B-HA/HA35)
por: Jia, XiaoXiao, et al.
Publicado: (2023)

Inhibition of cell invasion and migration by CEACAM1-4S in breast cancer
por: Yang, Changcheng, et al.
Publicado: (2017)

Acquired resistance to combination treatment through loss of synergy with MEK and PI3K inhibitors in colorectal cancer
por: Bhattacharya, Bhaskar, et al.
Publicado: (2016)

Overexpression of Specific CD44 Isoforms Is Associated with Aggressive Cell Features in Acquired Endocrine Resistance
por: Bellerby, Rebecca, et al.
Publicado: (2016)

Vitexin suppresses the proliferation, angiogenesis and stemness of endometrial cancer through the PI3K/AKT pathway
por: Liang, Cuixia, et al.
Publicado: (2023)

Hyaluronic Acid (HA), Platelet-Rich Plasm and Extracorporeal Shock Wave Therapy (ESWT) promote human chondrocyte regeneration in vitro and ESWT-mediated increase of CD44 expression enhances their susceptibility to HA treatment
por: Vetrano, Mario, et al.
Publicado: (2019)

STX-478, a Mutant-Selective, Allosteric PI3Kα Inhibitor Spares Metabolic Dysfunction and Improves Therapeutic Response in PI3Kα-Mutant Xenografts
por: Buckbinder, Leonard, et al.
Publicado: (2023)

The liberation of CD44
por: Cichy, Joanna, et al.
Publicado: (2003)

piRNA-31115 Promotes Cell Proliferation and Invasion via PI3K/AKT Pathway in Clear Cell Renal Carcinoma
por: Du, Xinghua, et al.
Publicado: (2021)

Low Molecular Weight Hyaluronan Induces Lymphangiogenesis through LYVE-1-Mediated Signaling Pathways
por: Wu, Man, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_t4jr4c6nnn4n9fu27kb9ti8loj